Benefits of hypoxic culture on bone marrow multipotent stromal cells.

Cultivation of cells is usually performed under atmospheric oxygen tension; however, such a condition does not replicate the hypoxic conditions of normal physiological or pathological status in the body. Recently, the effects of hypoxia on bone marrow multipotent stromal cells (MSCs) have been investigated. In a long-term culture, hypoxia can inhibit senescence, increase the proliferation rate and enhance differentiation potential along the different mesenchymal lineages. Hypoxia also modulates the paracrine effects of MSCs, causing upregulation of various secretable factors, including the vascular endothelial growth factor and interleukin-6, and thereby promoting wound healing and diabetic fracture healing. Finally, hypoxia plays an important role in mobilization and homing of MSCs, primarily by its ability to induce stromal cell-derived factor-1 expression along with its receptor, CXCR4. After transplantation, an ischemic environment, that is the combination of hypoxia and lack of nutrition, can lead to apoptosis or cell death, which can be overcome by the hypoxic preconditioning of MSCs and overexpression of prosurvival genes like Akt, HO-1 and Hsp70. This review emphasizes that hypoxia is an important factor in all major aspects of stem cell biology, and the mechanism involved in the hypoxic inducible factor-1signaling pathway behind these responses is also discussed.

[1]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[2]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[3]  K. Pienta,et al.  The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites , 2008, Leukemia.

[4]  Karim Oudina,et al.  Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. , 2007, Bone.

[5]  X. Chen,et al.  Lysophosphatidic Acid Protects Mesenchymal Stem Cells Against Hypoxia and Serum Deprivation‐Induced Apoptosis , 2008, Stem cells.

[6]  Mary Murphy,et al.  Metabolic Flexibility Permits Mesenchymal Stem Cell Survival in an Ischemic Environment , 2008, Stem cells.

[7]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Pochampally,et al.  Angiogenic Effects of Human Multipotent Stromal Cell Conditioned Medium Activate the PI3K‐Akt Pathway in Hypoxic Endothelial Cells to Inhibit Apoptosis, Increase Survival, and Stimulate Angiogenesis , 2007, Stem cells.

[9]  H. Haider,et al.  Sca-1+ Stem Cell Survival and Engraftment in the Infarcted Heart: Dual Role for Preconditioning-Induced Connexin-43 , 2009, Circulation.

[10]  D. Kemp,et al.  Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. , 2006, Biochemical and biophysical research communications.

[11]  David J. Anderson,et al.  Culture in Reduced Levels of Oxygen Promotes Clonogenic Sympathoadrenal Differentiation by Isolated Neural Crest Stem Cells , 2000, The Journal of Neuroscience.

[12]  S. Hung,et al.  Efficient expansion of mesenchymal stem cells from mouse bone marrow under hypoxic conditions , 2013, Journal of tissue engineering and regenerative medicine.

[13]  M. Longaker,et al.  Transient Changes in Oxygen Tension Inhibit Osteogenic Differentiation and Runx2 Expression in Osteoblasts* , 2004, Journal of Biological Chemistry.

[14]  Y. Tang,et al.  Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. , 2005, Journal of the American College of Cardiology.

[15]  N. Zhang,et al.  Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy , 2008, Journal of endocrinological investigation.

[16]  R. Schäfer,et al.  Hypoxia reduces the inhibitory effect of IL-1beta on chondrogenic differentiation of FCS-free expanded MSC. , 2009, Osteoarthritis and cartilage.

[17]  M. Hermiston,et al.  Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1–Mediated Inflammatory Response , 2011, Science Translational Medicine.

[18]  L. Neckers,et al.  Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.

[19]  Helen M. Blau,et al.  Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury , 2002, Cell.

[20]  M. Ahlers,et al.  Hypoxic Conditions during Expansion Culture Prime Human Mesenchymal Stromal Precursor Cells for Chondrogenic Differentiation in Three-Dimensional Cultures , 2011, Cell transplantation.

[21]  Ling Wei,et al.  Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.

[22]  Darwin J. Prockop,et al.  Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo , 2007, PloS one.

[23]  Yuri Kim,et al.  Oxygen and Cell Fate Decisions , 2008, Gene regulation and systems biology.

[24]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[25]  R. Pochampally,et al.  Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Regina Brunauer,et al.  Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan , 2007, Aging cell.

[27]  Loïc Royer,et al.  Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. , 2010, Experimental cell research.

[28]  M. Doran,et al.  Enhanced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells in Low Oxygen Environment Micropellet Cultures , 2010, Cell transplantation.

[29]  He Huang,et al.  Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. , 2011, Stem cells and development.

[30]  P. Tropel,et al.  Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential , 2010, Cell and Tissue Research.

[31]  S. Lim,et al.  Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. , 2011, Regenerative medicine.

[32]  Eamonn R. Maher,et al.  Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.

[33]  Zhiyun Xu,et al.  Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. , 2008, Microvascular research.

[34]  Jun Jiang,et al.  Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. , 2009, International journal of cardiology.

[35]  L. Poellinger,et al.  Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.

[36]  M. Cieśla,et al.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. , 2012, Antioxidants & redox signaling.

[37]  Shih-Hwa Chiou,et al.  Enhancement of Wound Healing by Human Multipotent Stromal Cell Conditioned Medium: The Paracrine Factors and p38 MAPK Activation , 2011, Cell transplantation.

[38]  E. Anokhina,et al.  Effect of hypoxia on stromal precursors from rat bone marrow at the early stage of culturing , 2007, Bulletin of Experimental Biology and Medicine.

[39]  R. Bolli,et al.  Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction , 2004, Circulation research.

[40]  Takashi Nakamura,et al.  Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. , 2010, Biochemical and biophysical research communications.

[41]  O. Lee,et al.  In utero transplantation of human bone marrow‐derived multipotent mesenchymal stem cells in mice , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[42]  V. Eder,et al.  Multipotential Mesenchymal Stem Cells Are Mobilized into Peripheral Blood by Hypoxia , 2006, Stem cells.

[43]  W M Miller,et al.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model. , 2001, Biophysical journal.

[44]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[45]  Patrick J Prendergast,et al.  Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: A role for AKT and hypoxia‐inducible factor (HIF)‐1α , 2008, Journal of cellular physiology.

[46]  K. Francis,et al.  In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain , 2008, Experimental Neurology.

[47]  M. Bernaudin,et al.  Synergistic effects of CoCl2 and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells , 2006, Journal of Cell Science.

[48]  Y. Kassir,et al.  Monitoring meiosis and sporulation in Saccharomyces cerevisiae. , 1991, Methods in enzymology.

[49]  A. Caplan,et al.  Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.

[50]  J. Blanco,et al.  Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. , 2008, Experimental hematology.

[51]  S. Kitamura,et al.  Effect of Hypoxia on Gene Expression of Bone Marrow‐Derived Mesenchymal Stem Cells and Mononuclear Cells , 2007, Stem cells.

[52]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[53]  J. Karp,et al.  Mesenchymal stem cell therapy: Two steps forward, one step back. , 2010, Trends in molecular medicine.

[54]  C. Won,et al.  Responses of adipose-derived stem cells during hypoxia: enhanced skin-regenerative potential , 2009, Expert opinion on biological therapy.

[55]  C. Chiu,et al.  Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. , 2011, Blood.

[56]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[57]  R. Zhao,et al.  Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. , 2006, Biochemical and biophysical research communications.

[58]  D. Link,et al.  Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells , 2008, Stem cells.

[59]  K. Jin,et al.  Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat , 2005, Neurobiology of Disease.

[60]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[61]  A. Harris,et al.  Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia , 2007, Stem cells.

[62]  A. Meunier,et al.  Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. , 2007, Tissue engineering.

[63]  A. P. Zhambalova,et al.  Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under lower oxygen tension , 2009, Cell and Tissue Biology.

[64]  Suk-Won Song,et al.  Integrin‐Linked Kinase Is Required in Hypoxic Mesenchymal Stem Cells for Strengthening Cell Adhesion to Ischemic Myocardium , 2009, Stem cells.

[65]  E. Wagner,et al.  Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia , 2008, Nature.

[66]  Meijing Wang,et al.  Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.

[67]  J. Cao,et al.  Cyclosporin A pre‐incubation attenuates hypoxia/reoxygenation‐induced apoptosis in mesenchymal stem cells , 2008, Scandinavian journal of clinical and laboratory investigation.

[68]  M. Bernaudin,et al.  Concomitant inhibition of prolyl hydroxylases and ROCK initiates differentiation of mesenchymal stem cells and PC12 towards the neuronal lineage. , 2008, Biochemical and Biophysical Research Communications - BBRC.

[69]  Usha Nekanti,et al.  Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia , 2010, International journal of biological sciences.

[70]  Alice Wong,et al.  Osteogenic proliferation and differentiation of canine bone marrow and adipose tissue derived mesenchymal stromal cells and the influence of hypoxia. , 2012, Research in veterinary science.

[71]  G. Semenza,et al.  Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1* , 2006, Journal of Biological Chemistry.

[72]  Ingo Müller,et al.  Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells , 2010, BMC Cell Biology.

[73]  E. Nye,et al.  Pre‐culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials , 2012, Cell proliferation.

[74]  Wasim S Khan,et al.  Hypoxic conditions increase hypoxia-inducible transcription factor 2α and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients , 2007, Arthritis research & therapy.

[75]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[76]  Yu Jin Lee,et al.  Role of FAK phosphorylation in hypoxia-induced hMSCS migration: involvement of VEGF as well as MAPKS and eNOS pathways. , 2010, American journal of physiology. Cell physiology.

[77]  S. Hung,et al.  Hypoxia Inhibits Osteogenesis in Human Mesenchymal Stem Cells through Direct Regulation of RUNX2 by TWIST , 2011, PloS one.

[78]  W M Miller,et al.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. , 2001, Biophysical journal.

[79]  J. Werneck-de-Castro,et al.  Soluble Factors from Multipotent Mesenchymal Stromal Cells have Antinecrotic Effect on Cardiomyocytes in Vitro and Improve Cardiac Function in Infarcted Rat Hearts , 2012, Cell transplantation.

[80]  L. Deng,et al.  Characterization of MSCs from human placental decidua basalis in hypoxia and serum deprivation , 2010, Cell biology international.

[81]  Nadine Kabbani,et al.  Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.

[82]  M. Longaker,et al.  Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. , 2006, American journal of physiology. Cell physiology.

[83]  H. Haider,et al.  Supportive Interaction Between Cell Survival Signaling and Angiocompetent Factors Enhances Donor Cell Survival and Promotes Angiomyogenesis for Cardiac Repair , 2006, Circulation research.

[84]  Heesang Song,et al.  Mesenchymal Stem Cells Pretreated with Delivered Hph‐1‐Hsp70 Protein Are Protected from Hypoxia‐Mediated Cell Death and Rescue Heart Functions from Myocardial Injury , 2009, Stem cells.

[85]  Brian Keith,et al.  HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. , 2006, Genes & development.

[86]  Alan W. Flake,et al.  Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.

[87]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[88]  Meijing Wang,et al.  HIGH PASSAGE NUMBER OF STEM CELLS ADVERSELY AFFECTS STEM CELL ACTIVATION AND MYOCARDIAL PROTECTION , 2006, Shock.

[89]  S. Hung,et al.  Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. , 2012, Molecular cell.

[90]  H. Hsu,et al.  Mesenchymal stem cell‐conditioned medium facilitates angiogenesis and fracture healing in diabetic rats , 2012, Journal of tissue engineering and regenerative medicine.

[91]  Yuxin Lu,et al.  Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice. , 2012, Cytotherapy.

[92]  Cláudia Lobato da Silva,et al.  Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia , 2009, Journal of cellular physiology.

[93]  M. Post,et al.  Evidence for Transcriptional Regulation of the Glucose‐6‐Phosphate Transporter by HIF‐1α: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells , 2009, Stem cells.

[94]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[95]  I. Sekiya,et al.  Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality , 2002, Stem cells.

[96]  Robert A. Kloner,et al.  Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution , 2003, Circulation.

[97]  D. Cochran,et al.  The therapeutic potential of oxygen tension manipulation via hypoxia inducible factors and mimicking agents in guided bone regeneration. A review. , 2011, Archives of oral biology.

[98]  Feng Zhao,et al.  Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs , 2006, Journal of cellular physiology.